- Capability group
- Biotechnology & Health Technologies
- Domain
- Critical Technology · Hard Power
- Identifier
- factbase.org/cap/SXV2R9FW2K
- Reference
- Biomanufacturing Wikipedia
Papers
2.4k
2020–2024
Paper growth
+42%
2020–24 on 2015–19
Patent families
126.5k
2020–2024
Filed abroad
30%
families in more than one office
In the framework
What the capability covers and what it leaves to others, and the indicators it will be measured by.
Bounds
Covers biomanufacturing technology and capacity; the plants belong to Strategic Infrastructure, product markets to the economic domains, and sovereign production of countermeasures reads at this capability's make layer with the products under the therapeutics capability.
Lineage
Carried from v0.0 (formerly Biological manufacturing) with the same identifier; recast from a definition of biomanufacturing to the sovereign production capacity, the layer at which states now deliberately build.
Indicators
- biologics manufacturing capacityPending
- vaccine production capacityPending
- fermentation capacity installedPending
Research
Papers classified to the capability, by year and by the nation of their authors' institutions, 2020–2024. Read from the v0.0 research topic Biological manufacturing.
Papers by year
The five leading nations, papers by year
Share of papers, 2020–2024
Of papers with a known author nation; 31% have none and are left out.
- 1China14.4%306 papers
- 2India12.4%264 papers
- 3United States12.1%259 papers
- 4Germany3.8%82 papers
- 5South Korea3.7%78 papers
- 6United Kingdom3.4%72 papers
- 7Brazil3.0%65 papers
- 8Australia2.4%52 papers
- 9Italy2.3%49 papers
- 10Spain2.3%49 papers
Leading institutions, 2020–2024
By fractional count: each paper divided among its authors' institutions.
- 1Chinese Academy of Sciences9fractional papers
- 2Vellore Institute of Technology University6fractional papers
- 3Shanghai Jiao Tong University6fractional papers
- 4Zhejiang University5fractional papers
- 5Purdue University West Lafayette5fractional papers
- 6Tufts University4fractional papers
- 7University College London4fractional papers
- 8Zhengzhou University3fractional papers
- 9University of Chinese Academy of Sciences3fractional papers
- 10Universidad Politécnica de Madrid3fractional papers
Patents
Patent families by the nation of origin of their applicants and their earliest priority year, from the CPC and IPC classes the capability is read from. 2025 onwards is incomplete: families are published 18 months after priority.
Families by priority year
The five leading origins, families by year
53,073 applicants filed here in 2015–2024; the five largest held 2% of families (HHI 3 of 10,000: unconcentrated).
Share of families by origin, 2020–2024
- 1China66.6%84,298 families
- 2United States11.4%14,407 families
- 3Japan6.0%7,552 families
- 4South Korea5.4%6,893 families
- 5Germany1.5%1,903 families
- 6France0.9%1,138 families
- 7United Kingdom0.9%1,104 families
- 8Taiwan0.7%868 families
- 9Switzerland0.6%802 families
- 10Canada0.6%707 families
Applicants filing most internationally, 2015–2024
Families filed in more than one office, by applicant as the offices name them.
- 1UNIV CALIFORNIA975international families
- 2CJ CHEILJEDANG CORP564international families
- 3PIONEER HI BRED INT526international families
- 4HOFFMANN LA ROCHE453international families
- 5CENTRE NAT RECH SCIENT447international families
- 6INST NAT SANTE RECH MED389international families
- 7FUJIFILM CORP384international families
- 8HARVARD COLLEGE367international families
- 9UNIV LELAND STANFORD JUNIOR354international families
- 10UNIV KYOTO327international families
Classification read
- C12P Fermentation and enzyme processes for making compounds · 844.2k documents
- C12M Bioreactors, fermenters and cell-culture apparatus · 787.5k documents
- C12N5/00 Cell lines and cell culture · 584.5k documents
- C12N7/00 Viruses and viral vectors: preparation and purification · 127.2k documents
- C07K1/14 Protein extraction and purification · 103.4k documents
Shares inventions with
Capabilities whose classes the same families also fall in, by overlap (Jaccard).
- Synthetic Biology & Genetic Engineering31,960 families · 0.282
- Advanced Therapeutics, Vaccines & Medical Countermeasures24,652 families · 0.201
- Genomics & Biological Data8,295 families · 0.081
Companies
50 companies in this capability, across 8 regions. The leading 12:
- 1Thermo Fisher ScientificLargest supplier of bioprocess media, single-use systems and analytics, and through Patheon one of the largest biologics and viral-vector CDMOs.Equipment & materials
- 2Danaher (Cytiva, Pall)Its Cytiva and Pall units are the leading suppliers of chromatography resins, filtration, bioreactors and turnkey modular biologics plants (KUBio).Equipment & materials
- 3LonzaWorld's largest contract development and manufacturing organisation for biologics, cell and gene therapies, with mammalian and microbial capacity across Europe, US and Asia.Manufacture
- 4Samsung BiologicsOperates the world's largest single-site biologics manufacturing capacity at Songdo (over 780,000 L across Plants 1-5).Manufacture
- 5WuXi BiologicsChina's leading biologics CDMO with large single-use bioreactor networks in China, Ireland and Germany serving global drug developers.Manufacture
- 6Fujifilm (Fujifilm Diosynth Biotechnologies)Fujifilm Diosynth is a top-tier biologics CDMO building very large mammalian cell culture plants in Denmark and Holly Springs, North Carolina.Manufacture
- 7SartoriusSartorius Stedim Biotech is a leading maker of single-use bioreactors, filters, fluid management and cell culture media for biologics production.Equipment & materials
- 8Merck KGaA (MilliporeSigma)Its Life Science sector (MilliporeSigma) supplies filtration, chromatography, media and contract viral-vector and ADC manufacturing to the bioprocess industry.Equipment & materials
- 9CSLRuns one of the world's largest plasma-fractionation networks (CSL Behring) and, through CSL Seqirus, cell-based and egg-based influenza vaccine plants.Manufacture
- 10NovonesisFormed by merging Novozymes and Chr. Hansen, it is the world's largest industrial enzyme and microbial culture producer with vast fermentation capacity.Manufacture
- 11Serum Institute of IndiaWorld's largest vaccine manufacturer by doses, producing over 1.5 billion doses a year including measles, polio, HPV and malaria (R21) vaccines.Manufacture
- 12Boehringer Ingelheim (BioXcellence)Operates large in-house and contract (BioXcellence) biopharmaceutical production in Biberach, Vienna and Fremont, one of Europe's biggest biologics capacities.Manufacture
